Real-world study of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal tumors

N. Xu, H. Yan,C. Mao, Y. Chen, G. Zhang, G. Cheng, H. Jiang,J. Yan,M. Chen, N. Zhang,X. Wang,J. Zhang, X. Shen, G. Wang, W. Zheng,Z. Han, Z. Wang, L. Xu,L. Ding, R. Xu

ANNALS OF ONCOLOGY（2021）

引用 1|浏览34

暂无评分

摘要

The NCCN guidelines recommend that long-acting G-CSF be administered on days 2-4 after chemotherapy to prevent neutropenia. This study investigated the incidence of grade 3/4 neutropenia in patients (pts) with gastrointestinal tumors after administration of mecapegfilgrastim (a long-acting G-CSF) in a real-world setting.

查看译文

关键词

neutropenia,gastrointestinal tumors,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要